| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
2,490 |
1,643 |
$1.37M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
20,351 |
17,634 |
$502K |
| 92134 |
|
24,648 |
21,898 |
$429K |
| J9035 |
Injection, bevacizumab, 10 mg |
17,922 |
10,935 |
$235K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,417 |
6,669 |
$194K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
982 |
902 |
$58K |
| 92235 |
|
1,043 |
959 |
$22K |
| 92250 |
|
1,283 |
1,163 |
$12K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
256 |
248 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
225 |
185 |
$8K |
| J7999 |
Compounded drug, not otherwise classified |
4,872 |
3,605 |
$3K |
| 67210 |
|
13 |
13 |
$941.69 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14 |
12 |
$718.31 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
12 |
12 |
$683.14 |